Skip to content
Home/Companies/Biotech/MoglingBio

MoglingBio

Biotech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns MoglingBio?

MoglingBio is currently owned by KIZOO Technology Capital through KIZOO Evergreen (Balance Sheet) (2007 vintage), since 2022.

Hand-verified · updated 2026-07-03

KIZOO Technology Capital
Investor
KIZOO Technology Capital
KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusActive

More from KIZOO Evergreen (Balance Sheet)

Other portfolio companies in the same fund.

Reservoir Neuroscience
Active
BiotechUS· 2024
Cellvie
Cellvie
Active
BiotechSwitzerland· 2021
Elastrin Therapeutics
Elastrin Therapeutics
Active
BiotechUS· 2021
Revel Pharmaceuticals
Revel Pharmaceuticals
Active
BiotechUS· 2020
Cyclarity Therapeutics
Cyclarity Therapeutics
Active
BiotechUS· 2019
MAIA Biotechnology
Exited 2022
BiotechUS· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track MoglingBio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy MoglingBio?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on MoglingBio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue